๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Tumor
Clinical trial register · China

Tumor Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Hefei 4 Qingdao 4 Tianjin 4 Xiamen 3 Guangzhou 2
Narrow the registerReset
Recruitment status
Phase
Site location
Hefei4 Qingdao4 Tianjin4 Xiamen3 Guangzhou2
All 16 locations
Target enrolment
to

Tumor trials in China

19 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Trophoblast Cell-Surface Antigen 2 (Trop-2) Targeted PET/CT in Recurrent and Metastatic Thyroid Cancer
NCT07753499Tumor, Solid Tumor, Thyroid Cancer
The First Affiliated Hospital of Xiamen University
Not applicable
120
Xiamen
2026-08-01
Recruiting
Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases
NCT07464132Tumor, Cardiovascular Diseases, Pulmonary Fibrosis, Rheumatic Immune Diseases Involving Large Blood Vessels
Peking Union Medical College Hospital
Phase 1/2
30
Beijing
2025-12-17
Recruiting
Application of โถโธGa-FXX489 (NNS309) PET/CT Imaging in Diagnosis of Tumor Diseases.
NCT07144085Tumor, Metastatic Cancer
Yi Tian
Phase 1
30
Shenyang
2025-09-11
By invitation
Research on NI-FAPI-04 for the Treatment of Hypoxic and Fibroblast Activation Protein Related Tumors
NCT07822347Tumor
Peking Union Medical College Hospital
Phase 1/2
20
Beijing
2025-08-15
Not yet open
Study of Peripheral Blood CHI3L1 to Predict Tumor Response to Radiotherapy
NCT07071688Tumor, Radiotherapy, Biomarker
Nanfang Hospital, Southern Medical University
Observational
338
Guangzhou, Huizhou, Meizhou
2025-07-20
Recruiting
Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients
NCT06956144Tumor, Carbonic Anhydrase IX
The First Affiliated Hospital of Xiamen University
Observational
113
Xiamen
2025-05-09
Recruiting
AI-Driven Cancer Diagnosis and Prediction With EHR
NCT06791473Tumor
The Eye Hospital of Wenzhou Medical University
Observational
1,000,000
Guangzhou, Chengdu, Wenzhou
2025-01-19
Recruiting
Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors
NCT06819215Cancer, Neoplasms, Neoplasms, Breast, Tumor
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
Phase 1/2
188
Jinan
2024-10-30
Recruiting
Different Intraoperative Blood Pressure Management on Postoperative Cognitive Function in Tumor Patients๏ผˆPRECISION๏ผ‰
NCT06711432Tumor, Stroke
Zhejiang Cancer Hospital
Not applicable
214
Hangzhou
2024-09-18
Recruiting
68Ga-FAPI-Biotin PET/CT in Patients With Various Types of Cancer
NCT06740240Tumor
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1
30
Fuzhou
2024-03-01
Active, closed
XS005 Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM)
NCT06147505Tumor
Dushu Lake Hospital Affiliated to Soochow University
Phase 1/2
13
Suzhou
2023-10-29
Recruiting
68Ga-NK224 PET Imaging of PD-L1 Expression in Cancers
NCT06754345Tumor, PD-L1
The First Affiliated Hospital of Xiamen University
Observational
100
Xiamen
2023-05-30
Recruiting
Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases
NCT06690736CXCR4-related Disease, Tumor, Positron Emission Tomography, Metastasis
Tianjin Medical University
Not applicable
200
Hefei, Qingdao, Tianjin
2022-03-01
Recruiting
FAPI PET/CT in Various FAP-Related Disease Patients
NCT06688071FAP-related Disease, Tumor, Positron Emission Tomography, Metastasis
Tianjin Medical University
Observational
500
Hefei, Qingdao, Tianjin
2022-03-01
Recruiting
68Ga-FAPI PET/CT in Patients With Various Types of Cancer
NCT04499365Tumor, Positron-Emission Tomography, Metastasis
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1
500
Fuzhou
2020-08-15
Recruiting
Somatostatin Receptor PET/CT in SSTR-Related Disease Patients
NCT06690957SSTR-related Disease, Tumor, Positron Emission Tomography, Metastasis
Tianjin Medical University
Observational
500
Hefei, Qingdao, Tianjin
2019-02-01
Recruiting
Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease
NCT06725693GLP1-R-related Disease, Tumor, Insulinoma, Positron Emission Tomography
Tianjin Medical University
Observational
500
Hefei, Qingdao, Tianjin
2019-02-01
Rows per page Showing 1–19 of 19
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/tumor

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 19 of those studies listing the condition Tumor.

How many Tumor trials are recruiting in China?

14 of the 19 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 2 have not yet opened recruitment, 2 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Tumor), 19 studies
PhaseStudiesRecruitingShare
Observational8642.1%
Phase 1/24221.1%
Not applicable3315.8%
Phase 12110.5%
Phase EARLY_PHASE12210.5%

Most active sponsors

Lead sponsors with the most studies (Tumor)
Lead sponsorStudiesRecruiting
Tianjin Medical University44
The First Affiliated Hospital of Xiamen University33
First Affiliated Hospital of Fujian Medical University22
Peking Union Medical College Hospital21
Dushu Lake Hospital Affiliated to Soochow University10
Lian Yang10
Nanfang Hospital, Southern Medical University10
The Eye Hospital of Wenzhou Medical University11
Yi Tian11
Zhejiang Cancer Hospital11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.